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The relationship between bowel movement (BM) frequency and the risk of colorectal cancer was examined in a large cohort of
25731 men and 37198 women living in 24 communities in Japan. At enrolment, each participant completed a self-administrated
questionnaire on BM frequency and laxative use. Incidence rate ratios (IRR) with 95% confidence intervals (CI) were estimated using
Cox’s proportional-hazard model. During the follow-up period (average length 7.6 years), 649 cases of colorectal cancer, including
429 cases of colon cancer, were identified. Among women, subjects who reported a BM every 2–3 days had the lowest risk of
developing colorectal (IRR¼0.71, 95% CI¼0.52–0.97) and colon cancer (IRR¼0.70, 95% CI¼0.49–1.00), whereas those
reporting a BM every 6 days or less had an increased risk of developing colorectal (IRR¼2.47, 95% CI¼1.01–6.01) and colon cancer
(IRR¼2.52, 95% CI¼0.93–6.82) compared with those reporting X1 BM per day. A similar, but nonsignificant, association between
the frequency of BM and cancer risk was observed in men. There was no association between colorectal or colon cancer risk and
laxative use. Regulating BM frequency might therefore have a role in the prevention of colorectal cancer.
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An association between constipation and the risk of colorectal
cancer has long been noted. Prolonged intestinal transit time
might not only increase the duration of contact between
carcinogens in the stools and the gut wall, but could also
concentrate carcinogens by increasing colonic water absorption.
A meta-analysis of 14 case–control studies that examined the
association between constipation or infrequent bowel movements
(BMs) and colorectal cancer and found a statistically significant
48% increase in the pooled odds ratios for colorectal cancer in
association with constipation (Sonnenberg and Mu ¨ller, 1993).
Recent case–control studies have also reported a relatively
consistent positive relationship between constipation and color-
ectal cancer (Kotake et al, 1995; Le Marchand et al, 1997;
Ghadirian et al, 1998; Jacobs and White, 1998; Roberts et al, 2003).
Since bowel habits might be influenced by the presence of
colorectal cancer, retrospective studies cannot exclude the effects
of the cancer itself, as well as recall bias, on their results. However,
few prospective studies have addressed this issue. The only cohort
study, which had a 12-year follow-up period involving 84577
women, of colorectal cancer incidence and BM frequency or
laxative use reported negative results (Dukas et al, 2000). The
influence of BMs on male colorectal cancer has not been previously
studied prospectively.
We conducted a large cohort study to investigate the association
between bowel habits, laxative use, susceptibility to diarrhoea and
the colorectal cancer risk in Japanese men and women.
MATERIALS AND METHODS
All data were taken from the Japan Collaborative Cohort (JACC)
Study, the methods of which have been described in detail
elsewhere (Ohno and Tamakoshi, 2001). Briefly, the original study
population consisted of 110792 Japanese adults aged 40–79 years.
Enrolment began in 1988 and continued until the end of 1990 in 45
areas across Japan. Most subjects were recruited from the general
population or when undergoing routine health checks in the
municipalities. Written informed consent for participation was
obtained individually from subjects, with the exception of a few
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ystudy areas in which informed consent was provided at the group
level after explaining the aims of the study and confidentiality of
the data to community leaders. The study protocol was approved
by the Ethics Committee of Medical Care and Research of the
Fujita Health University School of Medicine, Japan.
Analyses were restricted to data from the 65184 participants
who lived in the 24 study areas in which cancer registries were
available. A further 58 subjects with a previous history of
colorectal cancer, and 2197 subjects for whom information about
bowel habits was not available, were excluded. Therefore, a total of
62929 individuals (25731 men and 37198 women) were involved
in this analysis.
All participants completed a self-administered questionnaire on
enrolment. This covered demographic characteristics and lifestyle
factors such as diet, tobacco smoking, alcohol consumption,
physical activity, BM frequency, susceptibility to diarrhoea and
laxative use over the past year. The alternative answers provided
on the questionnaire for the frequency of BM were: ‘daily’, ‘every
2–3 days’, ‘every 4–5 days’ and ‘every 6 days or less’. With regard
to laxative use, the questionnaire asked only whether the
participants used laxatives in the past one year at the time of
enrolment; additional data on the type of laxative, the reason for
use and the duration of use were not collected. Participants also
provided information about susceptibility to diarrhoea by
answering ‘yes’, ‘no’ or ‘neutral’ in response to the question: do
you often have diarrhoea?
Population registries in the municipalities were used to
determine the vital and residential status of subjects. Registration
of death is required under the Family Registration Law in Japan,
which applies throughout the country. Incidences of cancer were
confirmed using records from the population-based cancer
registries, which were supplemented by a systematic review of
death certificates (Ohno and Tamakoshi, 2001); in some areas,
medical records were also reviewed in major local hospitals. The
mortality-to-incidence ratio for colorectal cancer was 0.28 in the
cohort covered by the cancer registries. This figure is comparable
with those calculated in the most accurate population-based cancer
registries in Japan (Parkin et al, 2003), which indicates that most
cases of colorectal cancer were identified in the study population.
The follow-up period ran from the time of the baseline survey
through to the end of 1997 in all but three areas (in which it ran
until the end of 1994, 1995 and 1996, respectively). The end point
of the study was defined as the incidence of colorectal cancer (10th
Revision of the International Classification of Diseases, ICD-10:
C18–C20) or colon cancer (ICD-10: C18). The risk of rectal cancer
was not analysed separately because of the relatively small number
of cases observed. Subjects who moved out of the study area or
died from causes other than colorectal cancer were treated as
censored cases. During the study period, only 3.3% (2071) of the
participants were lost from the follow-up as a result of a change of
residence.
All analyses were carried out by sex using the SAS statistical
package release 8.2 (SAS Inc., Cary, NC, USA). Differences in
baseline characteristics between categories of BM frequency were
tested using the chi-squared (w
2) test or one-way analysis of
variance (ANOVA). The follow-up period for each participant was
calculated as the time between completing the questionnaire and
either the diagnosis of colon or rectal cancer, death, moving out of
the study area or the end of the study – whichever occurred first.
The incidence rate ratios (IRR) and 95% confidence intervals
(CI) for colorectal and colon cancer were estimated, by sex, using
Cox’s proportional-hazard model according to the levels of BM
frequency, laxative use and susceptibility to diarrhoea. The
categories of ‘every day’ for BM, ‘nonuse’ for laxative use and
‘no’ or ‘neutral’ for susceptibility to diarrhoea were used as
reference groups.
Analyses were adjusted for the following potential confounding
factors: age (continuous variable); body mass index (BMI)
calculated as weight (kg) [height (m)]
 2 and categorised as
‘X25kgm
 2’o r‘ o25kgm
 2’; intake frequency of green leafy
vegetables (‘daily’ or ‘not daily’); intake frequency of alcohol (‘X5
days per week’ or ‘o5 days per week’); current smoking status
(‘smoker’ or ‘nonsmoker’); time spent walking per day (‘p30min
or ‘430min’); history of colorectal cancer in parents or siblings
(‘yes’ or ‘no’); and age at leaving full-time education (‘X20 years’
or ‘o20 years’). For each covariate, missing values were treated as
an additional category and were included in the model. To
determine the influence of symptoms of colorectal cancer on bowel
habits, analyses were repeated excluding the first 3 years of follow-
up. In all cases, two-sided P-values o0.05 were considered to be
statistically significant.
RESULTS
Within the study group, 1.1% of men and 4.0% of women reported
infrequent BMs (every 4 days or less). The use of laxatives was
more common among women (14.7%) than men (6.9%), whereas
men were more likely to report frequent diarrhoea (20.3%) than
were women (9.7%).
Table 1 shows the baseline characteristics of the study
population by BM frequency. Regardless of sex, individuals who
reported infrequent BMs – compared with those who reported BMs
daily or every 2–3 days – had a lower average BMI, were less likely
to spend 430min walking per day and were more likely to use
laxatives.
A significant difference in the intake frequency of green leafy
vegetables and in smoking status across the BM groups was
observed only among women: those who reported BMs daily or
every 2–3 days were more likely to consume green leafy vegetables
daily and less likely to be smokers. In addition, women who
reported BMs every 2–3 days were, on average, younger than those
in the other BM groups. Alcohol consumption did not differ
between BM groups in women.
Among men, the number that reported daily alcohol intake
increased linearly with BM frequency. Male subjects who reported
BMs every 2–3 days had the lowest rate of frequent diarrhoea,
whereas the number of women who reported frequent diarrhoea
decreased linearly with BM frequency.
During the follow-up period (average length 7.6 years, standard
deviation 1.9), a total of 649 cases of colorectal cancer were
identified (379 in men and 270 in women), which included 429
cases of colon cancer (225 in men and 204 in women).
Age-adjusted IRRs were calculated for colorectal and colon
cancer according to BM frequency (not shown). Regardless of sex,
the ratios were o1.00 for subjects who reported BMs every 2–3
days relative to those who reported daily BMs: the IRRs for
colorectal cancer were 0.74 in men (95% CI¼0.51–1.09) and 0.71
in women (95% CI¼0.52–0.97), whereas the IRRs for colon
cancer were lower in men (0.45; 95% CI¼0.25–0.82) and the same
in women (0.71; 95% CI¼0.49–1.00). In contrast, the age-adjusted
IRRs for subjects who reported highly infrequent BMs (every 6
days or less) relative to those with daily BMs were 41.00: the IRRs
for colorectal cancer were 1.14 in men (95% CI¼0.16–8.10) and
2.53 in women (95% CI¼1.04–6.15), whereas the IRRs for colon
cancer were 1.78 in men (95% CI¼0.25–12.7) and 2.59 in women
(95% CI¼0.96–6.98).
Adjustment for potential confounding factors (as discussed
above) had no significant effects on the IRRs (Table 2).
Furthermore, even after excluding the first 3 years of follow-up,
there was a lower risk of colorectal or colon cancer in women who
reported BMs every 2–3 days relative to those who reported daily
BMs: the multivariate-adjusted IRRs were 0.64 for colorectal
cancer (95% CI¼0.43–0.96) and 0.68 for colon cancer (95%
CI¼0.43–1.05). Increased risks of colorectal and colon cancers
were also observed in association with highly infrequent BMs
Bowel movement and colorectal cancer risk
M Kojima et al
1398
British Journal of Cancer (2004) 90(7), 1397–1401 & 2004 Cancer Research UK
E
p
i
d
e
m
i
o
l
o
g
y(every 6 days or less), although they were not statistically
significant.
Table 3 shows the associations between laxative use, suscept-
ibility to diarrhoea and colorectal or colon cancer risk. There were
weak nonsignificant positive associations between laxative use and
cancer risk in both men and women, but no association between
cancer risk and frequent diarrhoea.
DISCUSSION
This is the first prospective study, to our knowledge, that has
reported a significant association between BM frequency and
colorectal cancer risk. Infrequent BMs were associated with a
significantly increased risk of colorectal cancer and a marginally
increased risk of colon cancer in women. A similar, but
Table 1 Background characteristics of the participants at baseline by BM frequency by sex
BM frequency
Men Women
Variable
X1per day,
(n¼22930)
Every 2–3
days,
(n¼2526)
Every 4–5
days,
(n¼222)
Every 6
days or
less,
(n¼53) P-value
a
X1per day,
(n¼25884)
Every 2–3
days,
(n¼9813)
Every 4–5
days,
(n¼1238)
Every 6 days
or less,
(n¼263) P value
a
Age (years)
Mean 57.6 59.7 62.5 65.9 o0.0001 58.4 57.3 57.4 58.8 o0.0001
s.d. 10.2 11.2 11.3 11.6 9.9 10.5 10.8 11.0
BMI (kgm
 2)
Mean 22.7 22.2 21.7 21.7 o0.0001 23.1 22.6 22.5 22.0 o0.0001
s.d. 3.0 2.9 3.1 3.6 3.6 3.0 3.1 3.0
Having green leafy
vegetables every day (%)
26.2 26.1 20.7 22.6 0.29 32.5 27.8 27.1 24.7 o0.0001
Daily alcohol drinking (%) 48.4 36.0 33.3 28.3 o0.0001 5.2 4.7 4.3 4.9 0.15
Current smokers (%) 50.3 48.9 51.8 47.2 0.55 4.5 4.7 8.1 11.4 o0.0001
Daily walking time
o30min (%)
25.9 32.3 38.3 50.9 o0.0001 22.4 26.6 31.9 37.3 o0.0001
Having family history of
colorectal cancer (%)
2.2 2.1 1.8 0.0 0.71 2.5 2.5 3.1 3.4 0.53
Age of final education
completed X20 years (%)
11.8 11.4 8.1 15.1 0.30 5.2 5.6 4.9 4.2 0.29
Use of laxatives (%) 4.6 21.8 46.2 60.5 o0.0001 8.5 24.1 48.5 64.3 o0.0001
Having frequent diarrhoea
(%)
20.7 16.5 20.1 18.8 o0.0001 10.7 7.6 6.4 3.8 o0.0001
BM¼bowel movement; BMI¼body mass index; ANOVA¼analysis of variance.
aTest for homogeneity of characteristics between categories of BM frequency, using ANOVA
(age, BMI) and w
2 (other variables).
Table 2 IRR for colorectal and colon cancer according to BM frequency by sex
Colorectal cancer Colon cancer
BM
Observed
person-years
No. of
cases
Multivariate-
adjusted
a IRR 95% CI
b
No. of
cases
Multivariate-
adjusted
a IRR 95% CI
b
Men
X1per day 175485 346 1.00 211 1.00
Every 2–3 days 18335 30 0.77 0.53–1.12 11 0.46 0.25–0.85
Every 4–5 days 1515 2 0.56 0.14–2.26 2 0.93 0.23–3.75
Every 6 days or less 321 1 1.16 0.16–8.27 1 1.86 0.26–13.4
Women
X1per day 196472 204 1.00 155 1.00
Every 2–3 days 72891 51 0.71 0.52–0.97 38 0.70 0.49–0.996
Every 4–5 days 8937 10 1.12 0.59–2.11 7 1.01 0.47–2.17
Every 6 days or less 1880 5 2.47 1.01–6.01 4 2.52 0.93–6.82
IRR¼incidence rate ratios; BM¼bowel movement; BMI¼body mass index.
aAdjusted for age, BMI, intake frequency of green leafy vegetables, daily alcohol drinking, current
smoking status, time spent for walking per day, family history of colorectal cancer and education.
bCI: confidence interval.
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not altered by adjusting for potential confounding factors or
excluding the first 3 years of follow-up from the analysis, which
indicated that the effects of the cancers themselves on bowel habits
were not responsible for the associations.
These results support the findings of recent case–control
studies and of the meta-analysis carried out by Sonnenberg and
Mu ¨ller (1993), which reported a significantly increased risk of
colorectal cancer in association with constipation or infrequent
BMs. However, the findings from the Nurses’ Health Study in the
United States – only one published prospective data on the
association between BM frequency and female colorectal cancer
risk (Dukas et al, 2000) – did not support an association between
infrequent BMs and the risk of colorectal cancer. One possible
reason for the discrepancy between these results and those of the
present study is that different criteria were used to define
‘infrequent BM’. The Nurses’ Health Study defined this as an
average frequency of ‘every third day or less’. However, in the
present study, a significantly increased risk of colorectal and colon
cancer was found only in subjects who reported BMs every 6 days
or less relative to those reporting daily BMs. Therefore, we suggest
that only highly infrequent BMs elevate the risk of colorectal
cancer.
Daily BMs were found to increase the risk of colorectal and
colon cancer compared with BMs every 2–3 days, in both men and
women. This observation is in line with the results of a previous
case–control study carried out in Japan (Kato et al, 1993).
However, the Nurses’ Health Study (Dukas et al, 2000) found no
difference in colorectal cancer incidence between subjects who
reported X2 BMs per day and those who reported BMs once per
day (multivariate-adjusted IRR¼0.89, 95% CI¼0.65–1.20). Un-
fortunately, limitations of the questionnaire used in the present
study precluded us from determining the risk associated with X2
BMs per day. On the basis of the combined findings of these
studies, we speculate that subgroups that have highly frequent BMs
might be at an increased risk of colorectal cancer. Experimental
studies have reported elevated levels of prostaglandin E2 (PGE2)i n
the gastrointestinal tract in many diarrhoeal states (Burakoff and
Percy, 1992), and increased levels of PGE2 might be associated with
carcinogenesis in the large intestine (Reddy et al, 1993). We did
not observe a significant association between self-reported
susceptibility to diarrhoea and colorectal cancer risk, and the
results of previous epidemiological studies (case–control studies
only) were inconsistent (Dales et al, 1979; Kune et al, 1987).
Similar to ‘constipation’, the definition of ‘diarrhoea’ is equivocal.
Some case–control studies have suggested that ‘soft’ or ‘loose’
faeces might increase the risk of colorectal cancer (Kato et al, 1993;
Inoue et al, 1995). To have a conclusion, additional data on factors
such as faecal consistency should be collected and analysed
together with data on susceptibility to diarrhoea and BM
frequency.
A weak nonsignificant positive association was found between
laxative use and the risk of colorectal cancer in both men and
women. Previously, the meta-analysis of Sonnenberg and Mu ¨ller
(1993) revealed a significant 46% increase in the risk of colorectal
cancer associated with the use of laxatives. On the other hand,
recent case–control studies (Jacobs and White, 1998; Nascimbeni
et al, 2002; Roberts et al, 2003) and a prospective study (Dukas
et al, 2000) found no relationship between these factors – although
Dukas et al suggested that some types of laxative might influence
intestinal pH and the metabolism of intestinal flora, thereby
modifying colorectal cancer risk. The effects of laxative type were
not investigated in the present study because of limitations of the
questionnaire. Further prospective studies investigating the types
of laxative and duration of use will be necessary to resolve this
question.
The risk of rectal cancer was not analysed independently
because of the small number of cases in the study group. Larger-
scale prospective studies will be necessary to reveal the effects of
bowel habits on the development of cancers of the large intestine at
specific sites.
There were some limitations to the scope of the present study.
For example, although the main risk factors for colorectal cancer
were adjusted for in the analysis, other factors such as aspirin use
and hormone replacement therapy in women might have
confounded the results. Also, bowel habits were evaluated only
through a self-reported questionnaire that was administered once
at the baseline; the reproducibility and validity of the responses of
subjects were therefore not confirmed.
In conclusion, this study shows that highly infrequent BMs can
increase the risk of colorectal cancer in both men and women.
Highly frequent BMs may also enhance this risk. Further
Table 3 IRR for colorectal and colon cancer according to laxative use and susceptibility to diarrhoea
Colorectal cancer Colon cancer
Observed
person-years No. of cases
Multivariate-
adjusted
a
IRR 95% CI
b No. of cases
Multivariate-
adjusted
a
IRR 95% CI
b
Men
Laxative use
No 155068 292 1.00 170 1.00
Yes 10015 33 1.28 0.89–1.86 20 1.31 0.81–2.11
Susceptibility to diarrhoea
Normal 143808 285 1.00 168 1.00
Having frequent diarrhoea 35775 68 1.08 0.82–1.41 40 1.08 0.76–1.53
Women
Laxative use
No 206189 183 1.00 137 1.00
Yes 33097 41 1.20 0.85–1.69 33 1.26 0.86–1.85
Susceptibility to diarrhoea
Normal 230880 224 1.00 173 1.00
Having frequent diarrhoea 23417 26 1.18 0.79–1.78 16 0.95 0.57–1.59
IRR¼incidence rate ratios; BMI¼body mass index.
aAdjusted for age, BMI, intake frequency of green leafy vegetables, daily alcohol drinking, current smoking status, time spent
for walking per day, family history of colorectal cancer and education.
bCI: confidence interval.
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clarify the risk associated with BMs for colorectal cancer by
subsite.
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